
Please try another search
By Davit Kirakosyan UBS upgraded Procter & Gamble Company (NYSE:PG) to Buy from Neutral and raised its price target to $163.00 from $157.00 as it believes the recent stock...
By Davit Kirakosyan Investing.com -- Here is your daily Pro Recap of the biggest dividend headlines you may have missed on InvestingPro. Start your free 7-day trial to get this...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your...
By Davit Kirakosyan Rivian Automotive Inc (NASDAQ:RIVN) shares plunged more than 8% after-hours following the company’s reported Q4 results, with revenues coming in at $663...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest dividend headlines you may have missed on InvestingPro since Friday. Start your free 7-day trial to...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your...
By Davit Kirakosyan Morgan Stanley downgraded Fulcrum Therapeutics (NASDAQ:FULC) to Equalweight from Overweight and cut its price target to $8.00 from $27.00. Shares plunged more...
By Davit Kirakosyan Workday (NASDAQ:WDAY) reported its Q4 results, with EPS of $0.99 coming in better than the consensus estimate of $0.89. Revenue grew 19.6% year-over-year to...
By Davit KirakosyanInvesting.com -- Here are some of the biggest headlines out of hedge funds and company top brass you may have missed on InvestingPro last week. Start your free...
By Davit KirakosyanInvesting.com -- Here are some of the biggest share buyback announcements you may have missed on InvestingPro this past week. Start your free 7-day trial to get...